170 likes | 485 Views
The World of West Coast Biotech: Needs and Opportunities. Franz F. Hefti July 2005. How Many Jobs?. Biotech Employees in California: 225,000 Source: State of California, 2004 Employment Development Department. How Many Pharmacologists?. ¼ PhD Pharmacologists
E N D
The World of West Coast Biotech: Needs and Opportunities Franz F. Hefti July 2005
How Many Jobs? Biotech Employees in California: 225,000 Source: State of California, 2004 Employment Development Department
How Many Pharmacologists? ¼ PhD Pharmacologists ~ 4000 positions in California
Technical Skill Needs Easy to recruit • Molecular Pharmacologists • only the very best Difficult to recruit • In vivo Pharmacologists • Behavioral Pharmacologists • Safety Pharmacologists and Toxicologists • Secondary functions: • Pharmacokinetics experts • Quality Assurance/Quality Control experts • Regulatory experts • Project managers
Drug Discovery and Development Genomic Info xx Studies ofDisease Mechanisms Safety testing Target Human Studies Phases 1,2,3 Lead Initial Biologic Animal studies Drug Drug Candidate efficacy in animal models pharmacokinetics
Molecule-based Neuropharmacology Class of receptors/channels/transporters Specific receptor/channel/transporter Molecular biology Can we link it to a disease?
Disease-mechanism based Neuropharmacology: Example Alzheimer Brain Blood APP X X Ab monomers TOXIC X X TOXIC Neuron Ab aggregates TOXIC X Activated microglia Microglia
Questions Addressed for Each Disease What do we know about the disease mechanism? What are the current drugs? • How were they found? • What are their targets and how do they work? • Can we make them better? How do we find new targets? • small molecules or biologics? How are the drug candidates further developed? • Are there predictive animal models? • How do we translate to human trials?
Mindset Needs Intellectual flexibility Motivation
Understanding of Industry Intellectual Property • Patent filings • Confidentiality Company status • Publicly traded • Private, pre-IPO • Fully-owned subsidiary Compensation • salary and bonus • stock options Contract • ‘at will’ employment Recruitment mechanisms • Networking • Website announcements
Accept “Flexible Job Stability” David L. Sloane, Ph.D. since 2004 Associate Director, Rinat Neuroscience 2000 -2003 Sr. Scientist, Chiron Corporation 1995- 2000 Scientist III Targeted Genetics 1993- 1995 Scientist II Syntex Research 1989-1993 Post-doc UCSF
Be Ready to Move SepracorBoston Oxford University UK Servier Paris, France SIBIA, Merck San Diego Bionomics Adelaide, Australia Mark Varney, Ph.D. VP Pharmacology, Sepracor Inc.
Adjust to Company Evolution RINAT NEUROSCIENCE IND: anti-NGF for pain Foundation by A. Rosenthal 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 Focus on cancer therapeutics Formation Neurosci. Res. Dept. GENENTECH Rinat-Genentech partnership agreement on anti-NGF Clinical studies with NGF in neuropathy Start of neuroscience research
Ability to Find ‘Life After the Bench’ Project Management Quality Control/Quality Assurance Regulatory Affairs • Organizational skills • Interpersonal skills • Managerial skills
Summary Expert technical skills Understanding of drug discovery and development Motivation and intellectual flexibility Understanding of industry Ability to change and adjust Willingness to move away from the bench